Imiphumo emibi ye-Asacol (i-Mesaline yomlomo, i-Pentasa, i-Mesasal, i-Salofalk)

Iimiphumo ezimbi ezibangelwa yiCandelo leMithi eliSebenzisa rhoqo

Yintoni i-Asacol?

I-Asacol (i-mesalamine) yi-5-aminosalicylic acid (5-ASA) echithwe ngo-Agasti 1997 ukwenzela unyango lwe-ulcerative colitis. I-Asacol isebenza ngokusemgangathweni emathunjini, ixinzelele ukuvuvukala okubangelwa yi-ulcerative colitis, enye yezona ndlela eziphambili zezifo zesibindi sokuvuvukala (IBD) . I-Asacol yayisetyenziswa ngamanye amaxesha ukuphatha olunye uhlobo lwe-IBD, isifo sikaCrohn.

Nangona kunjalo, kuye kwafundwa ngokusondeleyo kwaye iingcali ze-IBD ngoku zikholelwa ukuba i-mesalamine ayiyisebenzisi kakuhle ekuphatheni isifo sika-Crohn, kwaye ayisasetyenziselwa ukusetyenziswa ngokuqhelekileyo ekuphatheni le fomu ye-IBD.

I-Asacol iyinkunkuma yezobisi

I-Asacol ichazwa "isilondolozo" seziyobisi, oko kuthetha ukuba kunikwa ixesha elide ukunyanga i-ulcerative colitis. I-ulcerative colitis ibangela ukuvuvukala kwi-colon, phakathi kwezinye iimpawu kunye neempawu kuwo wonke umzimba. I-Asacol isetyenziselwa ukunqanda ukuvuvukala kwikholoni ekhoyo, kwaye iqala ukuqala ukusebenza kwiiveki ezi-3. Emva kokuvuvukala kungaphantsi kolawulo, izigulane zinqunywe ukuba le nkunkuma inokukunceda ukukhusela ezinye izifo zesifo ukuba zenzeke.

Esi sigxina sesondlo siyaziwa ukuba sinesibalo esiphantsi (umlinganiselo) wemiphumo emibi, nangona ezinye zisenokwenzeka. Ukulandela uluhlu lweziphumo ezinobungozi kunye nemiphumo emibi ye-Asacol.

Iziphumo eziPhakathi

Hlola kunye nogqirha wakho ukuba ngaba ziphi iziphumo ezilandelayo ziqhubeka okanye zixhalabisa:

Ngaphantsi kwexesha okanye ngokuqhelekileyo

Hlola kunye nogqirha wakho ukuba ngaba ziphi iziphumo ezilandelayo ziqhubeka okanye zixhalabisa:

Njalo Ukwazisa ugqirha

Engaqhelekanga

Kudala

Iimpawu zokugqithisa

Izilumkiso Nge-Asacol

I-Asacol ithathwa njengesikhuselekileyo, kodwa inxulumene nezinye iziganeko ezimbi ukuba abantu abathabatha le nkunkuma mabafanele bazi. Abanye abantu baye bahlakulela iingxaki kunye neentso zabo, kwaye kunconywa ukuba abantu abathathe le michiza banomsebenzi wabo weengso zihlolwe rhoqo rhoqo.

Abanye abantu baye bafumana iimpendulo ezingathandekiyo ezifanisa iimpawu zesifo sezilonda zesilonda, esiquka uhudo, intloko, kunye nesisu esiswini. Ukuphendulwa kwemizimba kuyenzeka, kwaye ugqirha kufuneka uxelelwe malunga naluphi na oluphambili lwempembelelo kwi-mesalamine okanye kwi- sulfasalazine .

Ngaphantsi

I-Asacol ngokuqhelekileyo ixhomekeke kakuhle ngabantu abaninzi, kwaye idla ngokusetyenziswa ixesha elide ngalabo abanezilonda zesilonda. Nangona kunjalo, njengaye naziphi na iziyobisi, kukho umphumo wemiphumo emibi kunye nemiphumo emibi. Kwabaninzi abantu abanemiphumo emibi, kodwa abantu abathatha iAsacol kufuneka baqaphele ukuba banokuphikisa, ukuphazamiseka kweentso, okanye ukunyuka kwesifo sohudo kunye nentlungu yesisu. Naluphi na uxhalaba malunga nemiphumo emibi ye-Asacol, qhagamshelana nogqirha wakho.

Ezinye iziphumo ezichazwe ngasentla zingenzeka kwezinye izigulane. Ukuba uqaphela nayiphi na imiphumo, khangela kogqirha wakho. Olu lwazi lubhekiselwe nje kuphela njengesikhokelo-soloko udibana nogqirha okanye ophmistri ngolwazi olupheleleyo malunga neyeza zokunyanga.

Umthombo:

> I-Actavis Pharma, Inc. "I-ASACOLĀ® HD (i-mesalamine) iipilisi zokulibala ngokukhawuleza, ukusetyenziswa komlomo I-Initial US Approval: 1987." pi.actavis.com.

ULichtenstein GR, uHanuer SB, uSandborn WJ; I-Practice Parameters Ikomiti ye-American College of Gastroenterology. "Ukulawulwa kwesifo sikaCrohn kubantu abadala." Am J Gastroenterol. 2009 Feb; 104 (2): 465-83; Imibuzo 464, 484.